Management Team

Dr. Edward Lin, Founder and CEO

Ed is a Yale-trained board-certified anesthesiologist, biomedical scientist and inventor, He is a proactive positive thinker and polymath who applies creativity and perseverance to attain uncommon results, including national recognition for his innovations and appealing patent application rejections three times before the Patent Trial and Appeal Board in the US and overseas and winning every time. Ed was Chairman of Anesthesiology at an Ohio hospital and Associate Professor of anesthesiology at Ohio U. He was also trained in internal and emergency medicine and was Henry Woodburn Fellow at Roswell Park Cancer Institute, the highest honor bestowed by SUNY at Buffalo Graduate School of Biomedical Sciences. He is the founder of Ingenious Technologies and has successfully commercialized some of his inventions, including a Class II medical device.

Bryan Lin, V.P. of Operations

Certified Project Management Professional and Lean Six Sigma Black Belt trained graduate of Lockheed Martin's two-year Operations Leadership Development Program, Bryan holds Masters degrees in both Industrial Engineering and Business Administration. Past experience includes operational management of manufacturing production lines, negotiation of multi-million dollar contracts, and leading international cross-functional teams and suppliers during the successful development and subsequent launch of Disney's MagicBand 2 as the program's sole quality manager.

Elsa Abruzzo, RAC, FRAPS, Director of Regulatory Affairs

Elsa is a biotech and medical device expert, and the founding partner of the consulting firm, Cygnus Regulatory with a 30+ year successful regulatory, quality, and clinical track record. Her work included transcatheter heart valves (TAVR), implantable biomaterials, surgical adhesives, embolic agents, stents and cardiac ablation devices. Elsa managed clinical trials and led regulatory strategies at companies such as Baxter, Cordis JNJ, CryoLife, etc. She has a B.S. in engineering from the University of Miami and is regulatory affairs certified (RAC) and a Regulatory Affairs Professional Society (RAPS) Fellow.

David Armstrong, DPM, MD, PhD

A Professor of Surgery at the University of Southern California and founder and co-Director of the Southwestern Academic Limb Salvage Alliance (SALSA), Dr. Armstrong has produced more than 460 peer-reviewed research papers in dozens of scholarly medical journals as well as over 80 book chapters. He is co-Editor of the American Diabetes Association’s (ADA) Clinical Care of the Diabetic Foot, now in its third edition.

Among Dr. Armstrong’s many other accolades include selection as one of the first six International Wound Care Ambassadors, recipient of the inaugural Georgetown Distinguished Award for Diabetic Limb Salvage, and youngest-ever member elected into the Podiatric Medicine Hall of Fame and youngest-ever recipient of the ADA’s Roger Pecoraro Award, the highest award given in the field.

H. Peter Lorenz, MD

Dr. Lorenz is Professor of Plastic & Reconstructive surgery, Stanford University Medical Center; Chief of Pediatric Plastic Surgery, Stanford Medical Center; Director of NIH-funded Hagey Laboratory for Pediatric Regenerative Medicine; author of numerous research publications. Dr. Lorenz was a founder of Stem Source, Inc., which is now part of the public company, Cytori Therapeutics. He is a nationally recognized authority on wound care and is a member of Bio-X, Stanford’s pioneering interdisciplinary biosciences institute

Joseph Hage, MBA

Mr. Hage is the Founder and CEO of Medical MarComm, a medical industry consultancy. A former executive of Cardiac Science, Joe heads the Medical Device Group, the world’s largest organization for medical device professionals on LinkedIn, with over 340,000 members. Joe is well versed in issues affecting the medical device industry and possesses a wealth of executive marketing experience in both medical devices and consumer industries.